TLR expression in human melanoma cells

被引:22
作者
Saint-Jean, Melanie [1 ,2 ]
Knol, Anne-Chantal [1 ]
Nguyen, Jean-Michel [3 ]
Khammari, Amir [1 ,2 ]
Dreno, Brigitte [1 ,2 ]
机构
[1] CHU Hotel Dieu, Immunodermatol Lab, F-44093 Nantes 1, France
[2] CHU Hotel Dieu, Oncodermatol Unit, CIC Biotherapie INSERM 0503, F-44093 Nantes 1, France
[3] CHU Nantes, Epidemiol & Biostat Dept, F-44093 Nantes 1, France
关键词
innate immunity; melanoma; toll-like receptors; TOLL-LIKE RECEPTORS; TUMOR-INFILTRATING LYMPHOCYTES; STAGE-III MELANOMA; METASTATIC MELANOMA; TOPICAL IMIQUIMOD; ADOPTIVE TRANSFER; ADJUVANT THERAPY; CANCER-THERAPY; IN-VITRO; IMMUNITY;
D O I
10.1684/ejd.2011.1526
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
There is increasing evidence that melanoma cells express TLR2, -3, and -4. However, the expression of other TLRs by these cells still remains unknown. We investigated the expression patterns of TLR2, -3, -4, -7, -8 and -9 both on melanoma-invaded lymph nodes and on melanoma cell lines. TLR2, -3, -4, -7 and -9mRNA expression was determined by quantitative RT-PCR. The TLR protein expression level was measured ex vivo by immunohistochemistry and in vitro by flow cytometry. Results: At the mRNA level, melanoma cells in vitro, and possibly ex vivo, expressed TLR2, -3, -4, -7 and -9. TLR2 and -4 protein expressions ex vivo were over 50%, contrasting with an absence of these 2 TLRs in vitro. On the contrary, TLR-3 and -8 proteins had a low expression ex vivo with a high expression in vitro. TLR-7 and -9 proteins were expressed ex vivo and in vitro. Our study demonstrates for the first time that melanoma cells express TLR7 and -8.
引用
收藏
页码:899 / 905
页数:7
相关论文
共 25 条
[1]   Imiquimed treatment of lentigo maligna: An open-label study of 34 primary lesions in 32 patients [J].
Buettiker, Urs V. ;
Yawalkar, Nikhil Y. ;
Braathen, Lasse R. ;
Hunger, Robert E. .
ARCHIVES OF DERMATOLOGY, 2008, 144 (07) :943-945
[2]   In vitro induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in keratinocytes by boron and manganese [J].
Chebassier, N ;
El Houssein, O ;
Viegas, I ;
Dréno, B .
EXPERIMENTAL DERMATOLOGY, 2004, 13 (08) :484-490
[3]   Cancers take their Toll - the function and regulation of Toll-like receptors in cancer cells [J].
Chen, R. ;
Alvero, A. B. ;
Silasi, D-A ;
Steffensen, K. D. ;
Mor, G. .
ONCOGENE, 2008, 27 (02) :225-233
[4]   Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma [J].
Dréno, B ;
Nguyen, JM ;
Khammari, A ;
Pandolfino, MC ;
Tessier, MH ;
Bercegeay, S ;
Cassidanius, A ;
Lemarre, P ;
Billaudel, S ;
Labarrière, N ;
Jotereau, F .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (10) :539-546
[5]   An exploratory study of systemic administration of the Toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma [J].
Dummer, Reinhard ;
Hauschild, Axel ;
Becker, Juergen C. ;
Grob, Jean-Jacques ;
Schadendorf, Dirk ;
Tebbs, Veronica ;
Skalsky, Jeannine ;
Kaehler, Katharina C. ;
Moosbauer, Stephanie ;
Clark, Ruth ;
Meng, Tze-Chiang ;
Urosevic, Mirjana .
CLINICAL CANCER RESEARCH, 2008, 14 (03) :856-864
[6]   Polymorphisms in Toll-like receptor genes and risk of cancer [J].
El-Omar, E. M. ;
Ng, M. T. ;
Hold, G. L. .
ONCOGENE, 2008, 27 (02) :244-252
[7]   Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline [J].
Garbe, Claus ;
Peris, Ketty ;
Hauschild, Axel ;
Saiag, Philippe ;
Middleton, Mark ;
Spatz, Alain ;
Grob, Jean-Jacques ;
Malvehy, Josep ;
Newton-Bishop, Julia ;
Stratigos, Alexander ;
Pehamberger, Hubert ;
Eggermont, Alexander .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (02) :270-283
[8]   SELECTIVE EXPANSION OF A SPECIFIC ANTITUMOR CD8+ CYTOTOXIC LYMPHOCYTE-T CLONE IN THE BULK CULTURE OF TUMOR-INFILTRATING LYMPHOCYTES FROM A MELANOMA PATIENT - CYTOTOXIC ACTIVITY AND T-CELL RECEPTOR GENE REARRANGEMENTS [J].
GERVOIS, N ;
HEUZE, F ;
DIEZ, E ;
JOTEREAU, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (04) :825-831
[9]   Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors [J].
Goto, Yasufumi ;
Arigami, Takaaki ;
Kitago, Minoru ;
Nguyen, Sandy L. ;
Narita, Norihiko ;
Ferrone, Soldano ;
Morton, Donald L. ;
Irie, Reiko F. ;
Hoon, Dave S. B. .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) :3642-3653
[10]   TLR signaling by tumor and immune cells: a double-edged sword [J].
Huang, B. ;
Zhao, J. ;
Unkeless, J. C. ;
Feng, Z. H. ;
Xiong, H. .
ONCOGENE, 2008, 27 (02) :218-224